Seizure detection and neuromodulation: A summary of data presented at the XIII conference on new antiepileptic drug and devices (EILAT XIII)

- The last day of the Thirteenth Eilat Conference on Antiepileptic Drugs and Devices (EILAT XIII) focused solely on new medical devices and neuromodulation.
- The current article summarises the presentations focusing first on EEG- and ECG based methods and devices for seizure detection.
- Novel cardiac-based methods of vagal nerve and responsive deep brain stimulation rely on the prediction or early detection of seizures.

The Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIII) took place in Madrid, Spain from June 26th to 29th 2016. For the first time, the last day of the conference focused solely on new medical devices and neuromodulation. The current article summarises the presentations of that day, focusing first on EEG- and ECG based methods and devices for seizure detection. These methodologies form the basis for novel cardiac-based methods of vagal nerve and responsive deep brain stimulation that rely on the prediction or early detection of seizures and that are also included in this article.